{"name":"Aeglea Biotherapeutics","slug":"aeglea-biotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQcC15di1POWhzQ0hiV2hUeDVpcElkcFdzY3dSc2k5UXhSWkZNSlZpc3V5bkdIc24xdm8tU0hRcU1vcnQzeFBwYlBCc1BVdUJqdEc3ZzlFcnBsa09KQ3ZXQ1ptQ1BIZVhTZjF2Q01xUUFyeEU0TFBZZGJnOUVUUmVRUEFnbmozV2xzelJTRlNqd1ZvREZTZVNjaFVKdDRsNk5XaVBWRjQyRGpOdFVfX3BB?oc=5","date":"2026-02-24","type":"regulatory","source":"Fierce Pharma","summary":"Immedica overcomes prior FDA rebuke for ultrarare disease med to score new approval - Fierce Pharma","headline":"Immedica overcomes prior FDA rebuke for ultrarare disease med to score new approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPX1BUaFNMekV3Sks5akRka05nS2lRUENReGZ3b19SSjBuWl9BRDZUTTdVTmczX3QzbnZqS2Y0OGtzbmZPaU1nNlRJYkpFRTRrZlRtSVh2TzZkLXFjaTVXams2YUlyX3pWdUpTNTJkdnM1dDVSYXBPTkljbWZrMHYxcDBtLTlYcGJIVUtmSGFHb0pDQVl2aDJ5MA?oc=5","date":"2026-02-24","type":"regulatory","source":"BioWorld News","summary":"Immedica wins US FDA nod for Loargys to treat ARG1-D - BioWorld News","headline":"Immedica wins US FDA nod for Loargys to treat ARG1-D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdEIxV2t3SGJoMGthWVNWTXg4emtjN21ycG1kM081aEhHUjNlM0xZLTltWmZYWjRENk5FYm5zbXY2aVhhTE1ITWxwdzhER3MwbzA0cnlfY3d1bnUwYjlLOXBOQnJrdjJFZW1kVXcwc2Joc0o3WUVReG9KeUo3M19wVG1FYVNreTBlLTYtQlVld1FCc0o1cW1ORkg5bW1hZkJRZUxzT2FpWko?oc=5","date":"2023-12-08","type":"pipeline","source":"BioPharma Dive","summary":"Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs - BioPharma Dive","headline":"Spyre Therapeutics raises $180 million to advance anti-inflammatory drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2023-11-27","type":"pipeline","source":"prnewswire.com","summary":"Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands Leadership Team to Develop Next-Generation Therapeutic Combinations for the Treat","headline":"Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics, Appoints CEO and Additional Directors, and Expands L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOQUFNUFdaSXN1ZTZMMGh0QV9sRndMaUFqV2dpbXJaVnVmWjRTam5vLU1hMEoxQk4tU2xRZU1CaEsxYjVMSWdNU2pXb3Rpdl9PRDhMNV83TENYR0JHOVFjVkwzYmJUdEpYdkl1YkpkUzhNZnZfYjVsSUZ2Rkk5SDlobzNfQWI?oc=5","date":"2023-11-27","type":"pipeline","source":"Medical Marketing and Media","summary":"Aeglea rebrands to Spyre Therapeutics, names new CEO amid leadership changes - Medical Marketing and Media","headline":"Aeglea rebrands to Spyre Therapeutics, names new CEO amid leadership changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYm80VGhHQ1pFQ1FOdEdNa3JKVXVqTmltR0tPRVlGcXliN1lFdXd5cVRwbVdCdHFBREdMUkFCX3RTQ3VDTVQ4eUV5T0prSWxUSUZFSGstSFY5dTZUTjQ2dmtfcktoR3cyN2RUdXZ1X1hlLXBUZFlkOFZDRTZSTm9DeUt0OTNPOFAxbHVncHk1aEstTm9lRWtSbkhwWmNiaE9DcUE?oc=5","date":"2023-10-05","type":"regulatory","source":"Pharma Voice","summary":"FDA’s ‘ivory tower thinking’ ignores promising biomarkers, says a rare disease CEO - Pharma Voice","headline":"FDA’s ‘ivory tower thinking’ ignores promising biomarkers, says a rare disease CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVFJyM1ZWZWMwMmFNS0lzNTIxLTZ5eUNRQ1h6MG9hRzN1UVVRR2tzUmpPTEJ4dU11QmNCd1dJTDJmcERuWS1RazB3Y2x5MngybDY5MGItd2JsSEZpQm5UeFJucEJoNG5xUER4NjRQY0dQbXZLeWNBLVRqNlBkN28xcWcyOGxDWXM1d0x2dUFucXB1RVpfN2F6M3I3ZGE3ajRsTEVWdlJvOA?oc=5","date":"2023-07-27","type":"pipeline","source":"fiercebiotech.com","summary":"Immedica takes embattled rare disease asset off Aeglea's hands for $15M cash - fiercebiotech.com","headline":"Immedica takes embattled rare disease asset off Aeglea's hands for $15M cash","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOV1VNR1BvWFNTOWZtZllhTkg4di1OMmdzTWZQTlFIcjFMSXpxeWVqTUpsVE1tTS1IdEp4VTVlSVJpbkFzbzdsdDFRejAyZ0F3RWJTQ2pPYnNUMVBES1dNNlhpY2lBM2d0WFlacmhLUmw0Q1VhZkVYd1BTVjROakxpM1F0czlmeDI1N0tYRG9ZN0NKUFlBVWY0LVdRb1VRRjJlR0ZuUFdxQ05VWlVNcUd0RE9nMm02U2ZFdmVINC04aC0zY19lRUpVTGFn?oc=5","date":"2023-07-27","type":"pipeline","source":"prnewswire.com","summary":"Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma - prnewswire.com","headline":"Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQaTJORUgwLTFTa3RUa3B5SmZTeWh5OHR2NXFUSzJFeFFCa2VUcTVVQVd0d2xESGtFaDYyTGc2dTdob2MwbDU0OE53OWVXckNfaTB5aFNvNHVZOXZyTHF2dzc1ODJnU0JNcG5WZUplOUhpV2lTUjRQNkx2akhPamxnUzhDNmctRldJSzdSUldFdk8?oc=5","date":"2023-06-22","type":"deal","source":"BioPharma Dive","summary":"Spyre, a new biotech spinout, launches via merger with Aeglea - BioPharma Dive","headline":"Spyre, a new biotech spinout, launches via merger with Aeglea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPbDNjX25YUG9kN0haajIxU2hmRWZaN3kyMWtGNHlCQ1kyRjJqbTYwU3ZEYjVxRjh1Unp2ZVJScW9LSVBKSXlibExjcnUtVEVzSEFTS2RyNDNxRGdpVWpxSzdzVnlYTWVhd2x1YmI2Q2wzUmFjM3dEdUpGV2xUMXFEQmd5cl9jd3RvMURKMWItRGlkV0hIbzdLMUp6emR5OHEzVWlRNThjT0FVQTUwdm5BNktTZw?oc=5","date":"2022-06-02","type":"regulatory","source":"fiercebiotech.com","summary":"In a rare rebuke, FDA refuses to fully review Aeglea's rare disease drug application - fiercebiotech.com","headline":"In a rare rebuke, FDA refuses to fully review Aeglea's rare disease drug application","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNYUM0X0FXOVA3bTQ5YWVjbVNMaWhmMmlDcVVZd1M2c0d4a3ZrQ3BpSTB1aGhCMHZ6Y2NaelNmLWkwQjZxRVd4R3FTdkx1SnkyN3llcDIyTFF3V1JXWFhVTFcwWHVZT19EcnlXT1FhRzJPWU1KU3p0ZW54TUpndXNoVHdtSTJmQTBjcHc?oc=5","date":"2017-01-19","type":"trial","source":"The University of Texas at Austin","summary":"Study suggests enzyme safely starves cancer cells - The University of Texas at Austin","headline":"Study suggests enzyme safely starves cancer cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOMVctNlJONHk3dzA5RXBfZ2RETklpYVVXRWpRR1doZjlRSDdKc0tOcC1mcHlPdUpEdWZaRDB3UHQybTN6LXhjODBKRW1PbzhPbU43NmJoTVZXcXM2TFZuSWp0OUtmbmYza3UtWU1qSkJDNlRnNlZUOE5pelVzMHRsMTBBLWt3RXhLVzJBUXN4YTVidGdhRnNGN1Nia3liUVdVTDB2WUc0c0wtdTZQZnU5V09pRlE?oc=5","date":"2016-05-02","type":"pipeline","source":"24/7 Wall St.","summary":"Can Shares of Aeglea BioTherapeutics Really More Than Double? - 24/7 Wall St.","headline":"Can Shares of Aeglea BioTherapeutics Really More Than Double? - 24/7 Wall St.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}